Canada Markets open in 3 hrs 40 mins

COMPASS Pathways plc (CMPS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
10.75+0.05 (+0.47%)
At close: 04:00PM EDT
11.40 +0.65 (+6.05%)
After hours: 06:41PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close10.70
Open11.17
Bid0.00 x 2200
Ask0.00 x 1300
Day's Range10.49 - 11.51
52 Week Range6.54 - 49.51
Volume282,718
Avg. Volume307,604
Market Cap448.61M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    COMPASS Pathways presents largest ever study of psilocybin therapy, at American Psychiatric Association annual meeting

    Hear Professor David Hellerstein talk about the study Positive data from phase IIb study shows potential of COMP360 psilocybin therapy in treatment-resistant depression London, UK – 23 May 2022 COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, today presented positive data from the largest randomised, controlled, double-blind study of psilocybin therapy ever completed, at the Ameri

  • GlobeNewswire

    COMPASS Pathways to participate in upcoming Citi’s Biopharma Virtual Co-Panel Day and H.C. Wainwright Global Investment Conference

    LONDON, May 12, 2022 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will participate in two upcoming events as follows: Citi’s Biopharma Virtual Co-Panel Day: panel “Mood Disorders/Mental Health Panel” at 11:00 am ET on 18 May 2022HC Wainwright Global Investments Conference: presentation at 9:00 am ET on 24 May 2022 A live audio webcast of

  • GlobeNewswire

    COMPASS Pathways plc announces first quarter 2022 financial results and business highlights

    LONDON, May 10, 2022 (GLOBE NEWSWIRE) -- Highlights: End of phase II meeting held with FDAAward of Innovation Passport as part of the UK MHRA Innovative Licensing and Access Pathway ILAPFinalising phase III in TRD program design to be ready for second half of 2022Pioneering collaboration with King’s College London and South London and Maudsley NHS Foundation Trust, to create The Centre for Mental Health Research and Innovation in the UKCash position at 31 March 2022 of $243.7 millionConference c